In the last five years, this company grew its share price by 22.01%, with an estimated long-term EPS growth of roughly 24%, and a 10-year revenue CAGR of a whopping 40%.
Great article. MELI is on my portfolio as well. Thank you.
Thank you, I appreciate it! How's the position treating you so far?
Great article. MELI is on my portfolio as well. Thank you.
Thank you, I appreciate it! How's the position treating you so far?